6b

David Bishai (@dbishai) is a professor at the Johns Hopkins Bloomberg School of Public Health (@JohnsHopkinsSPH) and the leader of the Teaching Vaccine Economics Everywhere project (@TVEE4). His major research interest is the economics of public health practice. Bishai’s current projects focus on the connection between the operations at national, state and local health departments and improved population health. 

Bill Padula (@DrWmPadula) is Assistant Professor of Pharmaceutical and Health Economic at the University of Southern California (@SchaefferCenter @USC). He has taught economic evaluation modeling curriculum extensively throughout the U.S. and globally. In 2017, he and colleagues collaborated with the Maryland Attorney General to pass bipartisan Maryland State legislation to restrict price hikes on generic pharmaceuticals.



6a

Mark Jit (Mark.Jit@lshtm.ac.uk) is the Professor of Vaccine Epidemiology at the London School of Hygiene & Tropical Medicine (@LSHTM) and in the Modelling and Economics Unit of Public Health England, and a core member of the Vaccine Impact Modeling Consortium (@vaccineimpact). His work in epidemiological and economic modelling of infectious disease control interventions has informed immunisation policy on a range of vaccines in both developed and developing countries.

Raymond Hutubessy (hutubessyr@who.int) is a Senior Health Economist at the World Health Organization (WHO). He is the Executive Secretary of the WHO Immunization and Vaccines related Implementation Research (IVIR) Advisory Committee. As the lead economist at the Immunization, Vaccine and Biologicals Department, he sponsors and conducts research in vaccine economics and modelling of vaccine preventable diseases (@WHO). 

Teo Ying Yik (ephtyy@nus.edu.sg) is the Dean of the Saw Swee Hock School of Public Health, National University of Singapore (@NUSingapore). , and concurrently the iOmics Programme Leader at the Life Sciences Institute, and an Associate Faculty Member of the Genome Institute of Singapore. Prof Teo has served as the Director for the Centre for Infectious Disease Epidemiology and Research, where the Centre works closely with the Ministry of Defence to develop capabilities for disease surveillance, consultation and research to deter and to control potential infectious disease outbreaks. 



5b

Grace Chee (gchee@r4d.org) is a health economist with over 20 years of experience in health systems strengthening, health financing, costing analysis, and evaluation of global health programs. She leads the team from Results for Development (@Results4Dev) that coordinates the Learning Network for Countries in Transition (@Gavi_LNCT), which brings countries transitioning away from Gavi support together with peers and technical experts to address challenges that could impede a successful transition.

Vladimer Getia (kh.getia@ncdc.ge) is the Head of State Health Programme Department at the National Center for Disease Control and Public Health Georgia (@NCDCGeorgia). His work at the various government agencies includes the planning and implementation, procurement and funding of health programs. He leads the administration and current roll-out of the immunization electronic system, and he is responsible for vaccine supply in country with the support of UNICEF.

Natia Gulua (@nati_gulu) is the Deputy Head of Budget Department at the Ministry of Finance of Georgia (@mofgeorgia). Previously, she was head of Financial and Budget division at the Ministry of Labour, Health, and Social Affairs in Georgia. She holds a Master’s degree on organization and management of foreign economic affairs from Ivane Javakhishvili Tbilisi State University.



5a

Logan Brenzel (@loganbrenzel) is a health economist with more than 35 years of health financing and development experience worldwide, including working with ministries of health and finance on approaches to priority setting, sustainable financing, and health financing/reform. Logan manages a portfolio of investments on immunization financing and economics for the BMGF, and works with Gavi on health systems and sustainability technical working groups (@GatesFoundation).

Raymond Hutubessy (hutubessyr@who.int) is a Senior Health Economist at the World Health Organization (WHO). He is the Executive Secretary of the WHO Immunization and Vaccines related Implementation Research (IVIR) Advisory Committee. As the lead economist at the Immunization, Vaccine and Biologicals Department, he sponsors and conducts research in vaccine economics and modelling of vaccine preventable diseases (@WHO). 

Tommy Wilkinson (tommy.d.wilkinson@gmail.com) is a health economist and clinical pharmacist. He was the health economics lead for iDSI in sub-Saharan Africa, where he led research and technical assistance projects aimed at strengthening priority setting and health technology assessment (HTA) in South Africa and in sub-Saharan Africa (@idsihealth). In addition to working with iDSI, Tommy is a lecturer at the health economics unit at University of Cape Town and a consultant economist with Health, Nutrition and Population Global Practice at the World Bank.

Jhoney Barcarolo (jbarcarolo@gavi.org) is the Head of Immunisation Financing and Sustainability at the Gavi Secretariat in Geneva (@GAVI) where he manages Gavi’s strategic engagement on issues related to co-financing, transition and sustainability. Prior to Gavi, Jhoney served in advisory and strategy positions at WHO, the World Bank, the Brazilian Government, and in the private sector.

Gloria Ikilezi (gri@uw.edu) is a research scientist at the Institute of Health metrics and Evaluation (@IHME_UW). She recently completed her doctorate in Global Health Metrics and Implementation Science at the University of Washington. Gloria is a physician/epidemiologist by training, and her work includes a range of research activities at the Infectious Diseases Research Collaboration in Uganda, with a more recent focus on program evaluation and resource tracking for immunization at IHME. Her main interests involve implementation and evaluation of maternal and child health programs in developing countries.

4b

Kelsey Vaughan (@kelseyvaughan @ThinkwellGlobal) is a health economist with over ten years of public health experience in government, universities, research institutions and private consultancies in Europe, Latin America and the United States. Ms. Vaughan is the costing lead for the Immunization Costing Action Network (ICAN) project, including a systematic review on the costs of delivering vaccines in LMICs and 4 country costing studies.

Inge van der Putten (i.vanderputten@maastrichtuniversity.nl) is an assistant professor at Maastricht University (@MaastrichtU). Her recent work includes identification, prioritization, and evaluation of the broader impact of immunization beyond immediate health gains and cost savings; as well as looking into societal perspectives in economic analyses. She holds a PhD, MSc in Global Health and Health Policy,  and a BA from Maastricht University. 

Allison Portnoy (aportnoy@mail.harvard.edu) is a doctoral student at Harvard University (@HarvardChanSPH @GHP_HarvardChan). Her research focus is on costing and evaluating vaccine delivery strategies in LMICs using modeling analyses. Prior to joining Harvard, Allison was a research associate at the International Vaccine Access Center at Johns Hopkins. She holds an MSPH from Johns Hopkins and a BA from Stanford University.

Bryan Patenaude (bpatena1@jhu.edu) is an assistant professor at the Johns Hopkins University (@IVACtweets @JohnsHopkinsIH). His research interests include health system strength, sustainability, and efficiency in LMIC, and the medium and long-term impact of health investments on non-health sectors. Previously a senior economist at the USAID, he has a wealth of background experience working on the HIV/AIDS epidemic in sub-Saharan Africa.

4a

Annette Ozaltin (aozaltin@thinkwell.global) is a Health Financing Director at ThinkWell (@ThinkWellGlobal) leading the Immunization Costing Action Network (ICAN) project, focused on building country capacity to generate and use evidence on the cost of delivering vaccines. She works to develop innovative solutions to health systems and financing challenges.

Maryam Huda (@Maryam_huda67) is a Senior Instructor at the Aga Khan University (AKU), Karachi, Pakistan, and the Director Urban Health program, a community-campus partnership and stakeholder collaborative operating in disadvantaged squatter settlements (@AKUGlobal). Her recent works include Vaccine economics and financing and mHealth. She holds an MBBS and a Masters in Health Policy and Management from AKU

Arthorn Riewpaiboon (arthorn.rie@mahidol.ac.th) is an associate professor at the Division of Social and Administrative Pharmacy, Faculty of Pharmacy, Mahidol University, Thailand. (@mupharm) He wrote a chapter of Measuring Cost in the Thai National HTA Guidelines and developed the standard cost lists for HTA. He is an experienced consultant for the International Vaccine Institute and WHO working in more than 10 countries in Asia and Africa.

Anthony Ssebagereka (@ssebagereka) is a research associate at the Coalition for Health Promotion and Social Development (@HEPS-Uganda) and was a research fellow at Makerere University co-investigating the DOVE Cost of illness study (@MakHPPM @MakSPH). He holds a Master’s of Health Service Research from Makerere University and a Bachelor’s degree in Pharmacy from Mbarara University

Gatien de Broucker (@g_debroucker) is a field health economist at IVAC (@IVACtweets @JohnsHopkinsIH). He cares about the sustainable development of universal health coverage, integrating evidence and community engagement in program and project management in local health systems and in the humanitarian effort globally.

3ib

Stephen Resch (sresch@hsph.harvard.edu) is the Deputy Director of the Center for Health Decision Science at Harvard (@HarvardChanSPH @decisionscience). He has conducted health economic research on a wide range of topics from maternal health interventions, WHO’s Safe Childbirth Checklist, and PAHO’s ProVac Initiative. He leads the Expanded Program on Immunization Costing (EPIC) project funded by the Bill and Melinda Gates Foundation.



3ia

Kelsey Vaughan (@kelseyvaughan @ThinkwellGlobal) is a health economist with over ten years of public health experience in government, universities, research institutions and private consultancies in Europe, Latin America and the United States. Ms. Vaughan is the costing lead for the Immunization Costing Action Network (ICAN) project, including a systematic review on the costs of delivering vaccines in LMICs and 4 country costing studies.

Annette Ozaltin (aozaltin@thinkwell.global) is a Health Financing Director at ThinkWell (@ThinkWellGlobal) leading the Immunization Costing Action Network (ICAN) project, focused on building country capacity to generate and use evidence on the cost of delivering vaccines. She works to develop innovative solutions to health systems and financing challenges.

Frédéric Debellut (fdebellut@path.org) is a Health Economist at PATH with 10 years international experience in managing health related projects both at global and country levels with a specific focus on immunization (@PATHtweets). He provides technical support to countries in carrying out economic evaluations including costing analyses of new vaccine introductions and cost effectiveness. His work also involves forecasting demand for different vaccines.



3rb

Libby Watts (ewatts13@jhmi.edu) is a Research Data Analyst on IVAC’s Economics and Finance team (@IVACtweets @JohnsHopkinsIH). She works on economic models for the Decade of Vaccine Economics (DoVE) project and is a research coordinator for the TyVAC Cost of Illness study in Nepal. Libby holds an MHS in International Health Economics from Johns Hopkins University, and a BA in Economics and Mandarin Chinese from Kenyon College.

Gatien de Broucker (@g_debroucker) is a field health economist at IVAC (@IVACtweets @JohnsHopkinsIH). He cares about the sustainable development of universal health coverage, integrating evidence and community engagement in program and project management in local health systems and in the humanitarian effort globally.

3ra

Bill Padula (@DrWmPadula) is Assistant Professor of Pharmaceutical and Health Economic at the University of Southern California (@SchaefferCenter @USC). He has taught economic evaluation modeling curriculum extensively throughout the U.S. and globally. In 2017, he and colleagues collaborated with the Maryland Attorney General to pass bipartisan Maryland State legislation to restrict price hikes on generic pharmaceuticals.

Shreena Malaviya (@sheens93) is a health economist with a strong focus towards decision modeling and simulation, global health, health financing and policy. She manages the Teaching Vaccine Economics Everywhere project (@TVEE4) aimed to develop the skill set of mid-career policymakers and researchers in South Africa, Uganda, India, and Pakistan. She holds an MSc in Health Economics from JHSPH, and a BS from McGill University



2b

David Bloom (@davidebloom) is Clarence James Gamble Professor of Economics and Demography at Harvard. His work focuses on health, demography, education, and labor. He has written extensively on education in developing countries and on the links among health status, population dynamics, and economic growth. Dr. Bloom has published over 300 articles, book chapters, and books.

JP Sevilla (jsevilla@hsph.harvard.edu) earned a Ph.D. in Economics at Harvard University, and a J.D. from George Mason University. He is a Research Associate at Harvard  (@HarvardChanSPH @GHP_HarvardChan) and a Senior Economist at Data for Decisions. His expertise is in the economic and normative aspects of global health, cost- benefit analysis and public sector priority-setting, law and economics, and applied econometrics and microeconomics. 

Maddalena Ferranna (mferranna@hsph.harvard.edu) is a research fellow at Harvard (@HarvardChanSPH @GHP_HarvardChan). Her research and teaching interests include Economics of Risk and Uncertainty, Environmental Economics and Welfare Economics. She is interested in the impact of risk on public decision making, by taking into account incomplete markets, sustainability and fairness, and different representations of risk preferences.



2a

Stephen Resch (sresch@hsph.harvard.edu) is the Deputy Director of the Center for Health Decision Science at Harvard (@HarvardChanSPH @decisionscience). He has conducted health economic research on a wide range of topics from maternal health interventions, WHO’s Safe Childbirth Checklist, and PAHO’s ProVac Initiative. He leads the Expanded Program on Immunization Costing (EPIC) project funded by the Bill and Melinda Gates Foundation.

Laura Boonstoppel (lboonstoppel@thinkwell.global) is an economist focused on health financing and immunization financing. Her expertise includes costing, resource mapping, fiscal space analysis, and developing forecasting models. At ThinkWell (@ThinkwellGlobal), she currently leads ICAN’s work on campaign costing, and has worked on strategic purchasing assessments, allocative efficiency studies, health labor market analyses, and other health financing studies.

Ann Levin (ann@levinmorgan.com) is a Health Economist with 25 years of experience conducting economic analyses and modelling in the areas of health and health sector reform in low and middle-income countries. She has a PhD in Health Economics from Johns Hopkins University and has extensive experience working in developing countries. Levin has developed several tools for conducting cost projections of introduction of new vaccines.  

Sarah Pallas is an economist in the CDC’s Global Immunization Division (@CDCGlobal), where she conducts economic evaluations of immunization interventions and provides technical guidance on economics, finance, and budgeting for global immunization programs. She previously worked on implementation, evaluation, and expenditure tracking for HIV/AIDS programs, and has published research on donor proliferation in development assistance for health, scaling up health interventions, and improving health service delivery performance. She holds a PhD in Health Policy and Management from Yale, an MPhil from Cambridge, and a BA from Harvard.

1c

Susmita Chatterjee (schatterjee@georgeinstitute. org.in) is a senior health economist at the George Institute for Global Health India (@GeorgeInstIN). She has a PhD from the University of Calcutta, and has worked on several health economics projects in the areas of mental health, diabetes, cholera, typhoid, tuberculosis and immunization. She was previously Associate Professor at the Public Health Foundation of India (PHFI).

Emma Clarke (@Emma_C_Clarke) is a fourth year PhD student in population health sciences at Harvard. Her recent works include evaluation of maternal health programs in Kenya, evaluation of India’s national immunization outreach program, and a systematic review and simulation study on cost estimators used in LMIC costing studies. Prior to beginning her PhD, she worked as the programme officer at Gavi, the Vaccine Alliance. 

1b

Annette Ozaltin (aozaltin@thinkwell.global) has 15 years of experience in global health policy, health systems, and health financing. She has worked with various developmental organizations to design and implement policies and programs for health systems performance improvement in LMIC. At ThinkWell (@ThinkWellGlobal), Annette works on developing innovative solutions to health systems and financing challenges.

Hoang Van Minh (hvm@huph.edu.vn) is currently Deputy-Dean for research of the Hanoi School of Public Health. He specialises in epidemiology, biostatistics and health economics. He has particular interest in doing research about healthcare system capacities for the prevention and control of the rising burden of non-communicable diseases in Vietnam.

Fatuma Manzi (fmanzi@ihi.or.tz) is a Principal Scientist based at Ifakara Health Institute (@ifakarahealth) for over 16 years. She is a health system and policy analyst with experience leading health systems and policy research projects. Dr Fatuma also has a wide experience with programs on community health workers, human resources, quality improvement at district managerial level, health facilities and community level. 

Amila Megraini (amila.megraini@yahoo.com) is a senior researcher at Universitas Indonesia, School of Public Health, and one of the leading members of the Center for Health Administration and Policy Studies (@fkmui @ui_cheps). Her expertise includes financial, quality, human resource management, Indonesia’s single payer system and the immunization, HIV/AIDS, and tobacco management programs

Vittal Mogasale (vmogalase@ivi.int) is the head of the Policy and Economic Research Department at the International Vaccine Institute, Seoul, South Korea (@IVIHeadquarters). His current work involves development of global vaccine invest- ment cases, vaccine demand and supply forecast, cost-effect- iveness analyses, cost of illness studies, private willingness to pay for vaccines and estimation of vaccination costing.



1a

Nicolas Menzies (nmenzies@hsph.harvard.edu) is Assistant Professor of Global Health and core faculty of the Harvard Center for Health Decision Science (@HarvardChanSPH @GHP_HarvardChan). He uses mathematical modeling to examine infectious disease control policy in high burden settings. Prior to joining Harvard he worked with the Global AIDS Program at the U.S. CDC on the economic evaluation of  HIV/AIDS control interventions.